Search

everythinglearnresearchcommunity

for

Search:↓

PRP injections improve hair thickness for baldness.

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Different soft tissue fillers can cause various skin reactions; biodegradable fillers are safer and non-biodegradable ones like silicone can lead to long-term problems.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

The hair follicle is a great model for research to improve hair growth treatments.

Chinese men have lower AGA rates than Caucasians, with type III vertex most common; family history is important.

AR polyglycine repeat doesn't cause baldness.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Higher iron levels in the blood are not linked to increased hair loss in women.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Goat reproductive activity and coat growth are affected by light and temperature, with temperature altering prolactin levels and hair growth, but not melatonin or estrus onset.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

58% of men aged 30-50 have hair loss, with severity increasing with age.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

The Trichoscan system was found to be inaccurate for measuring hair growth, needing better software to be useful.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.